Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cyclerion Therapeutics
Biotech
BIO announces new CEO—Chutes & Ladders
BIO lands rare disease advocate John Crowley as CEO. Cyclerion Therapeutics picks EQRx leader for top spot. Sensorium selects new CEO.
Gabrielle Masson
,
Annalee Armstrong
Dec 8, 2023 9:30am
Ex-J&J research chief lands at FogPharma—Chutes & Ladders
Mar 31, 2023 9:30am
Tour de biotech: Cyclerion peddles through another disease area
Oct 6, 2022 10:30am
Cyclerion fails sickle cell test, prompting pivot to CNS disease
Oct 14, 2020 8:40am
Cyclerion drug passes early neurodegenerative disease test
Jan 21, 2020 7:45am